Pre-Clinical Evidence Confirms Veyonda® Abscopal Effect


You May Also Like

ThromboGenics Business Update – FY 2017

Press release                                                          15 March 2018Regulated Information Advancing Preclinical and Clinical Diabetic Eye Disease Portfolio ...

Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Results

DUBLIN, Ireland, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), today announced ...